Atractylenolide III attenuates bleomycin-induced experimental pulmonary fibrosis and oxidative stress in rat model via Nrf2/NQO1/HO-1 pathway activation

References

• Zhou Z, Kandhare AD, Kandhare AA, et al. Hesperidin ameliorates bleomycin-induced experimental pulmonary fibrosis via inhibition of TGF-beta1/Smad3/AMPK and IkappaBalpha/NF-kappaB pathways. EXCLI Journal. 2019;18:723–745.
   PubMed Web of Science ®Google Scholar
• Richeldi L, Collard HR, Jones MG. Idiopathic pulmonary fibrosis. Lancet. 2017;389:1941–1952.
   PubMed Web of Science ®Google Scholar
• Raghu G, Collard HR, Egan JJ, et al.; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788–824.
   PubMed Web of Science ®Google Scholar
• Ley B, Collard HR, King TE Jr. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011;183:431–440.
   PubMed Web of Science ®Google Scholar
• Hutchinson J, Fogarty A, Hubbard R, et al. Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review. Eur Respir J. 2015;46:795–796.
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Suda T. Idiopathic pulmonary fibrosis: diagnosis and clinical manifestations. Clin Med Insights Circ Respir Pulm Med. 2015;9:163–171.
   PubMed Web of Science ®Google Scholar
• American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med. 2000;161(2 Pt 1):646–664.
   Web of Science ®Google Scholar
• Kurland G, Deterding RR, Hagood JS, et al. An official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy. Am J Respir Crit Care Med. 2013;188:376–394.
   PubMed Web of Science ®Google Scholar
• Nathan N, Berdah L, Borensztajn K, et al. Chronic interstitial lung diseases in children: diagnosis approaches. Expert Rev Respir Med. 2018;12:1051–1060.
   PubMed Web of Science ®Google Scholar
• Nathan N, Sileo C, Thouvenin G, et al. Pulmonary fibrosis in children. J Clin Med. 2019;8:1312.
   Web of Science ®Google Scholar
• Liu H, Dong H, Jiang L, et al. Bleomycin inhibits proliferation and induces apoptosis in TPC-1 cells through reversing M2-macrophages polarization. Oncol Lett. 2018;16:3858–3866.
   PubMed Web of Science ®Google Scholar
• Raghu G, Raghu G. Nintedanib and pirfenidone. New antifibrotic treatments indicated for idiopathic pulmonary fibrosis offer hopes and raises questions. Am J Respir Crit Care Med. 2015;191:252–253.
   PubMed Web of Science ®Google Scholar
• Laporta Hernandez R, Aguilar Perez M, Lázaro Carrasco M, et al. Lung transplantation in idiopathic pulmonary fibrosis. Med Sci. 2018;6:68.
   Google Scholar
• Hoang LS, Tran MH, Lee J-S, et al. Inflammatory inhibitory activity of sesquiterpenoids from Atractylodes macrocephala rhizomes. Chem Pharm Bull. 2016;64:507–511.
   PubMed Web of Science ®Google Scholar
• Wang M, Hu R, Wang Y, et al. Atractylenolide III attenuates muscle wasting in chronic kidney disease via the oxidative stress-mediated PI3K/AKT/mTOR pathway. Oxid Med Cell Longev. 2019;2019:1875471.
   PubMed Web of Science ®Google Scholar
• Ji Y, Kang Z, Kang N, et al. Atractylenolide III enhances the anti-neoplastic efficacy of docetaxel in gastric cancer cell by inhibiting fibroblast growth factor receptors 1, -2, and -4 expression. J Environ Pathol Toxicol Oncol. 2019;38:217–227.
   PubMed Web of Science ®Google Scholar
• Zhao H, Ji ZH, Liu C, et al. Neuroprotection and mechanisms of atractylenolide III in preventing learning and memory impairment induced by chronic high-dose homocysteine administration in rats. Neuroscience. 2015;290:485–491.
   PubMed Web of Science ®Google Scholar
• Ji G-Q, Chen R-Q, Wang L. Anti-inflammatory activity of atractylenolide III through inhibition of nuclear factor-κB and mitogen-activated protein kinase pathways in mouse macrophages. Immunopharmacol Immunotoxicol. 2016;38:98–102.
   PubMed Web of Science ®Google Scholar
• Yoou MS, Nam SY, Jin MH, et al. Ameliorative effect of atractylenolide III in the mast cell proliferation induced by TSLP. Food and chemical toxicology: an international journal published for the British Industrial. Food Chem Toxicol. 2017;106:78–85.
   PubMed Web of Science ®Google Scholar
• Kandhare AD, Bodhankar SL, Mohan V, et al. Effect of glycosides based standardized fenugreek seed extract in bleomycin-induced pulmonary fibrosis in rats: Decisive role of Bax, Nrf2, NF-κB, Muc5ac, TNF-α and IL-1β. Chem Biol Interact. 2015;237:151–165.
   PubMed Web of Science ®Google Scholar
• Delaunois A, Dedoncker P, Hanon E, et al. Repeated assessment of cardiovascular and respiratory functions using combined telemetry and whole-body plethysmography in the rat. J Pharmacol Toxicol Methods. 2009;60:117–129.
   PubMedGoogle Scholar
• Ding W, Zhang XY, Pan M, et al. Interleukin-17A promotes the formation of inflammation in the lung tissues of rats with pulmonary fibrosis. Experimental and Therapeutic Medicine. 2015;10:491–497.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Wang Y, Liang D, et al. Sodium tanshinone IIA sulfonate suppresses pulmonary fibroblast proliferation and activation induced by silica: role of the Nrf2/Trx pathway. Toxicol Res (Camb). 2016;5:116–125.
   PubMed Web of Science ®Google Scholar
• Wang YI, Li Q, Wei X, et al. Targeted knockout of TNF-α by injection of lentivirus-mediated siRNA into the subacromial bursa for the treatment of subacromial bursitis in rats. Mol Med Rep. 2015;12:4389–4395.
   PubMed Web of Science ®Google Scholar
• Gao F, Kinnula VL, Myllärniemi M, et al. Extracellular superoxide dismutase in pulmonary fibrosis. Antioxid Redox Signal. 2008;10:343–354.
   PubMed Web of Science ®Google Scholar
• Beeh KM, Beier J, Haas IC, et al. Glutathione deficiency of the lower respiratory tract in patients with idiopathic pulmonary fibrosis. Eur Respir J. 2002;19:1119–1123.
   PubMed Web of Science ®Google Scholar
• Bartoli ML, Novelli F, Costa F, et al. Malondialdehyde in exhaled breath condensate as a marker of oxidative stress in different pulmonary diseases. Mediators Inflamm. 2011;2011:1–7.
   Web of Science ®Google Scholar
• Lott JA, Stang JM. Serum enzymes and isoenzymes in the diagnosis and differential diagnosis of myocardial ischemia and necrosis. Clin Chem. 1980;26:1241–1250.
   PubMed Web of Science ®Google Scholar
• Kikuchi N, Ishii Y, Morishima Y, et al. Nrf2 protects against pulmonary fibrosis by regulating the lung oxidant level and Th1/Th2 balance. Respir Res. 2010;11:31.
   PubMed Web of Science ®Google Scholar
• Claussen CA, Long EC. Nucleic acid recognition by metal complexes of bleomycin. Chem Rev. 1999;99:2797–2816.
   PubMed Web of Science ®Google Scholar
• Chaudhary NI, Schnapp A, Park JE. Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model. Am J Respir Crit Care Med. 2006;173:769–776.
   PubMed Web of Science ®Google Scholar
• Grande NR, Peão MND, CMd S, et al. Lung fibrosis induced by bleomycin: structural changes and overview of recent advances. Scanning Microsc. 1998;12:487–494.
   Google Scholar
• Jona A, Miltenyi Z, Poliska S, et al. Effect of bleomycin hydrolase gene polymorphism on late pulmonary complications of treatment for hodgkin lymphoma. PloS One. 2016;11:e0157651.
   PubMed Web of Science ®Google Scholar
• Sebti SM, Mignano JE, Jani JP, et al. Bleomycin hydrolase: molecular cloning, sequencing, and biochemical studies reveal membership in the cysteine proteinase family. Biochemistry. 1989;28:6544–6548.
   PubMed Web of Science ®Google Scholar
• Plataki M, Koutsopoulos AV, Darivianaki K, et al. Expression of apoptotic and antiapoptotic markers in epithelial cells in idiopathic pulmonary fibrosis. Chest. 2005;127:266–274.
   PubMed Web of Science ®Google Scholar
• Uhal BD, Joshi I, Hughes WF, et al. Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung. Lung Cell Mol Physiol. 1998;275:1192–1199.
   PubMed Web of Science ®Google Scholar
• Pathol JC, Ferreira MA, Kairalla RA, et al. Evidence of type II pneumocyte apoptosis in the pathogenesis of idiopathic pulmonary fibrosis (IFP)/usual interstitial pneumonia (UIP). J Clin Pathol. 2001;54:132–138.
   PubMed Web of Science ®Google Scholar
• Kroemer G, Reed JC. Mitochondrial control of cell death. Nat Med. 2000;6:513–519.
   PubMed Web of Science ®Google Scholar
• Wang K-T, Chen L-G, Wu C-H, et al. Gastroprotective activity of atractylenolide III from Atractylodes ovata on ethanol-induced gastric ulcer in vitro and in vivo. J Pharm Pharmacol. 2010;62:381–388.
   PubMed Web of Science ®Google Scholar
• Fernandez IE, Eickelberg O. The impact of TGF-β on lung fibrosis: from targeting to biomarkers. Proc Am Thorac Soc. 2012;9:111–116.
   PubMedGoogle Scholar
• Redente EF, Keith RC, Janssen W, et al. Tumor necrosis factor-α accelerates the resolution of established pulmonary fibrosis in mice by targeting profibrotic lung macrophages. Am J Respir Cell Mol Biol. 2014;50:825–837.
   PubMed Web of Science ®Google Scholar
• Papiris SA, Tomos IP, Karakatsani A, et al. High levels of IL-6 and IL-8 characterize early-on idiopathic pulmonary fibrosis acute exacerbations. Cytokine. 2018;102:168–172.
   PubMed Web of Science ®Google Scholar
• Cinar R, Gochuico BR, Iyer MR, al. e. Cannabinoid CB1 receptor overactivity contributes to the pathogenesis of idiopathic pulmonary fibrosis. JCI Insight. 2017;2:e92281.
   PubMed Web of Science ®Google Scholar
• Sziksz E, Pap D, Lippai R, et al. Fibrosis related inflammatory mediators: role of the IL-10 cytokine family. Mediators Inflamm. 2015;2015:764641.
   PubMed Web of Science ®Google Scholar
• Eickelberg O, Laurent GJ. The quest for the initial lesion in idiopathic pulmonary fibrosis: gene expression differences in IPF fibroblasts. Am J Respir Cell Mol Biol. 2010;42:1–2.
   PubMed Web of Science ®Google Scholar
• Zhang K, Phan SH. Cytokines and pulmonary fibrosis. Biol Signals. 1996;5:232–239.
   PubMedGoogle Scholar
• Keane MP. The role of chemokines and cytokines in lung fibrosis. European Respiratory Review. 2008;17:151–156.
   Google Scholar
• Cheresh P, Kim SJ, Tulasiram S, et al. Oxidative stress and pulmonary fibrosis. Biochim Biophys Acta. 2013;1832:1028–1040.
   PubMed Web of Science ®Google Scholar
• Sies H. Oxidative stress: a concept in redox biology and medicine. Redox Biol. 2015;4:180–183.
   PubMed Web of Science ®Google Scholar
• Ratnam DV, Ankola DD, Bhardwaj V, et al. Role of antioxidants in prophylaxis and therapy: a pharmaceutical perspective. J Control Release. 2006;113:189–207.
   PubMed Web of Science ®Google Scholar
• Oury TD, Schaefer LM, Fattman CL, et al. Depletion of pulmonary ECSOD after exposure to hyperoxia. Am J Physiol Lung Cell Mol Physiol. 2002;283:777–784.
   PubMed Web of Science ®Google Scholar
• Crystal RG. Oxidants and respiratory tract epithelial injury: pathogenesis and strategies for therapeutic intervention. Am J Med. 1991;91:S39–S44.
   PubMed Web of Science ®Google Scholar
• Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med. 1991;11:81–128.
   PubMed Web of Science ®Google Scholar
• Åttingsberg E, Hoyer N, Wilcke T, et al. Lactate dehydrogenase as a biomarker of advanced disease in idiopathic pulmonary fibrosis. Eur Respir J. 2019;54:PA4701.
   Web of Science ®Google Scholar
• Zhang SX, Miller JJ, Stolz DB, et al. Type I epithelial cells are the main target of whole-body hypoxic preconditioning in the lung. Am J Respir Cell Mol Biol. 2009;40:332–339.
   PubMed Web of Science ®Google Scholar
• Emad A, Emad V. The value of BAL fluid LDH level in differentiating benign from malignant solitary pulmonary nodules. J Cancer Res Clin Oncol. 2008;134:489–493.
   PubMed Web of Science ®Google Scholar
• Zhang DD, Lo SC, Cross JV, et al. Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol Cell Biol. 2004;24:10941–10953.
   PubMed Web of Science ®Google Scholar
• Kobayashi A, Kang MI, Okawa H, et al. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol Cell Biol. 2004;24:7130–7139.
   PubMed Web of Science ®Google Scholar
• Cho H-Y, Reddy SP, Kleeberger SR. Nrf2 defends the lung from oxidative stress. Antioxid Redox Signal. 2006;8:76–87.
   PubMed Web of Science ®Google Scholar
• McMahon M, Itoh K, Yamamoto M, et al. The cap ‘n’ collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. Cancer Res. 2001;61:3299–3307.
   PubMed Web of Science ®Google Scholar